Third Party Funds as Moderating Variables of Liquidity Level of Sharia Commercial Banks
Indonesian Economic Review · 2021
DOI: 10.53787/iconev.v3i2.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Economic Review, 2021. Verfasst von Wahidatun Nafiah Alfarda und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study aims to examine the effect of BI 7-days (reverse) repo rate, sukuk, Bank Indonesia sharia certificates on the level of liquidity with third party funds as a moderating variable. The population in this study is all Islamic Commercial Banks in Indonesia. The sample in this study is the financial statements of Islamic banking statistics registered by OJK with 55 samples from June 2016-December 2020. The analytical technique of this study uses moderated regression analysis (MRA). The results of this study indicate that TPF can moderate the effect of the BI 7-days (reverse) repo rate and sukuk on FDR, but cannot moderate the effect of Bank Indonesia sharia certificates on FDR. Other results show that the BI 7-days (reverse) repo rate has a negative and significant effect on FDR, sukuk has a positive and significant effect on FDR and Bank Indonesia sharia certificates have a positive and significant effect on FDR.
Zitieren
APA
Alfarda, W. N., Nawawi, M. A. A., Rofiq, M. A., & Syafitri, R. I. (2021). Third Party Funds as Moderating Variables of Liquidity Level of Sharia Commercial Banks. Indonesian Economic Review. https://doi.org/10.53787/iconev.v3i2.10
Vancouver
Alfarda WN, Nawawi MAA, Rofiq MA, Syafitri RI. Third Party Funds as Moderating Variables of Liquidity Level of Sharia Commercial Banks. Indonesian Economic Review. 2021. doi:10.53787/iconev.v3i2.10
BibTeX
@article{Alfarda2021,
author = {Alfarda, Wahidatun Nafiah and Nawawi, Muhammad Afif An and Rofiq, Mohammad As’adur and Syafitri, Rizky Intan},
title = {Third Party Funds as Moderating Variables of Liquidity Level of Sharia Commercial Banks},
journal = {Indonesian Economic Review},
year = {2021},
doi = {10.53787/iconev.v3i2.10}
}
EUVIMED